Suppr超能文献

青光眼患者的球后/肌锥内引流管置入:艾哈迈德FP-7及引流管延长器病例系列,随访1年

Retrobulbar/intraconal tube placement in patients with glaucoma: Ahmed FP-7 and tube extender case series with 1 year follow-up.

作者信息

Laroche Daniel, Grodecki Brian, Grimes Kara Rickford, Ng Chester

机构信息

Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai Icahn School of Medicine, New York, NY, United States.

Department of Ophthalmology, Advanced Eyecare of New York, New York, NY, United States.

出版信息

Front Ophthalmol (Lausanne). 2025 Feb 25;5:1408897. doi: 10.3389/fopht.2025.1408897. eCollection 2025.

Abstract

PURPOSE

The Ahmed FP-7 valve is useful in the management of refractory glaucoma. However, this can often have ocular hypertensive phase and subconjunctival fibrosis that can lead to increased medication use and failure. We report how retrobulbar and intraconal plate placement with tube extension can avoid the ocular hypertensive phase, lower intraocular pressure, and reduce medication burden.

PATIENTS AND METHODS

This is a retrospective case series of 4 patients with glaucoma who underwent Ahmed FP-7 valve and retrobulbar/intraconal tube placement with a one-year follow-up.

RESULTS

One-year results in 4 patients with advanced glaucoma and pseudophakia revealed a pre-operative intraocular pressure of 21 mmHg on 5.5 medications. At one year, the post-operative intraocular pressure was 10.25 on 0 medications. The vision and visual fields were stable. One patient required drainage of a choroidal effusion and one patient required burping of viscoelastic on post-operative day one.

CONCLUSIONS

The combined insertion of the Ahmed FP-7 valve and silicone tube inserted into the retrobulbar/intraconal space has been shown to prevent ocular hypertensive phase, lower intraocular pressure, and reduce medication burden at one year.

摘要

目的

艾哈迈德FP - 7瓣膜在难治性青光眼的治疗中很有用。然而,这种治疗常常会出现眼压升高期和结膜下纤维化,进而导致用药增加和治疗失败。我们报告了通过球后和肌锥内植入带延长管的瓣膜如何避免眼压升高期、降低眼压并减轻用药负担。

患者和方法

这是一项回顾性病例系列研究,对4例青光眼患者进行了艾哈迈德FP - 7瓣膜植入及球后/肌锥内管植入,并进行了为期一年的随访。

结果

4例晚期青光眼和假晶状体患者的一年随访结果显示,术前眼压为21 mmHg,使用5.5种药物。一年后,术后眼压为10.25,未使用药物。视力和视野稳定。1例患者在术后第1天需要引流脉络膜积液,1例患者需要排出粘弹剂。

结论

已证明,联合植入艾哈迈德FP - 7瓣膜和插入球后/肌锥内间隙的硅胶管可预防眼压升高期,降低眼压,并在一年时减轻用药负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83e6/11893817/8501f04a3d68/fopht-05-1408897-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验